The latest image guidance solutions of Philips will be featured at Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC). The company, according to a press release, will showcase its continued commitment to addressing the needs of patients with the introduction of instant wave-free ratio (iFR) co-registration, which integrates iFR pullback data with the angiogram, and the third generation of HeartNavigator, live image guidance software for advanced structural heart disease procedures.
According to the press release, Philips image-guided therapy tools help clinicians decide, guide and confirm the right therapy for delivery of better care to help improve patient and economic outcomes. With iFR co-registration, clinicians can assess coronary artery blockages by using the Philips Volcano pressure measurement guidewires and equipment. There is no need for time-consuming pullback devices or guesswork.
Philips will also be introducing the third generation of its innovative HeartNavigator planning and guidance software that provides functionality to measure, select aortic valve repair device, and choose the X-ray viewing angle. With HeartNavigator, a 3D volume is rendered from previously acquired CT datasets and overlaid on live fluoro for real-time 3D guidance. The software provides an immersive user experience, giving physicians more confidence during challenging procedures, such as transcatheter aortic valve implantation (TAVI).
In addition to Philips image-guided therapy tools, the Philips booth (#1938) at TCT will also feature key integrated cardiology solutions including ultrasound imaging and healthcare IT that demonstrate the company’s strategy across the health continuum, from healthy living and prevention to diagnosis, treatment and home care. Philips also will host several events and offer live demonstrations, including iFR co-registration, at the Interactive Technology Center to allow attendees to better understand the clinical benefits of its offerings.
Bert van Meurs, business leader of image-guided therapy for Philips, comments: “Image-guided therapy is key to effective cardiovascular care, and Philips is committed to offering innovative solutions that enable more personalized care and better treatment for patients.The introduction of iFR co-registration adds to our robust suite of integrated solutions and strategies for cardiology that help healthcare professionals determine appropriate therapeutic approaches and deliver treatment with more confidence.”
- Lunch symposium: The future of physiology—exploring iFR co-registration and ischemia-guided PCI; 31 October, 11.30am–12.30am
- Dinner symposium: controversies in PCI optimisation—a case-based discussion; 1 November, 6pm–8pm